Australian pharmaceutical policy and the idea of innovation.
Disease mongering is now part of the global health debate
An observational study of the discrediting of COX-2 NSAIDs in Australia: Vioxx or class effect?
A prompt to the web: the media and health information seeking behaviour
Potency, hubris, and susceptibility: the disease mongering critique of pharmaceutical marketing
Are you sure you would like to clear your session, including search history and login status?